Hinge Health (NASDAQ: HNGE) Bessemer funds sell 337K shares

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) reported that entities affiliated with Bessemer Venture Partners sold shares of its Class A Common Stock. On August 25, 2026, Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P. sold shares at a weighted average price of $91.08, and on August 26, 2026 they sold additional shares at a weighted average price of $91.71. Reporting person Robinson Elliott is a partner at Bessemer Venture Partners and has only an indirect, passive economic interest in these securities and disclaims beneficial ownership except to the extent of any pecuniary interest.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Robinson Elliott

Role Director

Sold 0 shs ($0.00)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1, F2, F3	0	$0.00	$0.00
Sale	Class A Common Stock F1, F2	0	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 0 shares (Indirect, See footnote)

Footnotes (3)

1. F1. On August 25, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 115,202 and 108,144 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.08. These shares were sold in multiple transactions at prices ranging from $90.50 to $91.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2. F2. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.
3. F3. On August 26, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 58,484 and 55,243 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.71. These shares were sold in multiple transactions at prices ranging from $91.20 to $92.07. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Key Figures

Shares sold by BVP X on August 25, 2026: 115,202 shares of Class A Common Stock Shares sold by BVP X Institutional on August 25, 2026: 108,144 shares of Class A Common Stock Price range on August 25, 2026: $90.50–$91.20 per share +3 more

6 metrics

Shares sold by BVP X on August 25, 2026 115,202 shares of Class A Common Stock Sold at a weighted average price of $91.08

Shares sold by BVP X Institutional on August 25, 2026 108,144 shares of Class A Common Stock Sold at a weighted average price of $91.08

Price range on August 25, 2026 $90.50–$91.20 per share Multiple sale transactions by the Bessemer Funds

Shares sold by BVP X on August 26, 2026 58,484 shares of Class A Common Stock Sold at a weighted average price of $91.71

Shares sold by BVP X Institutional on August 26, 2026 55,243 shares of Class A Common Stock Sold at a weighted average price of $91.71

Price range on August 26, 2026 $91.20–$92.07 per share Multiple sale transactions by the Bessemer Funds

Key Terms

weighted average price, Class A Common Stock, beneficial ownership, pecuniary interest

4 terms

weighted average price financial

"sold ... shares ... at a weighted average price of $91.08"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Class A Common Stock financial

"shares of Class A Common Stock of the Issuer"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

beneficial ownership financial

"The Reporting Person disclaims beneficial ownership of the securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of his pecuniary interest, if any, in such securities"

FAQ

What insider transactions in HNGE stock were reported for August 25, 2026?

On August 25, 2026, Bessemer Venture Partners X L.P. sold 115,202 HNGE Class A shares and Bessemer Venture Partners X Institutional L.P. sold 108,144 shares at a weighted average price of $91.08, in multiple transactions between $90.50 and $91.20.

What insider transactions in HNGE stock were reported for August 26, 2026?

On August 26, 2026, Bessemer Venture Partners X L.P. sold 58,484 HNGE Class A shares and Bessemer Venture Partners X Institutional L.P. sold 55,243 shares at a weighted average price of $91.71, in multiple transactions between $91.20 and $92.07.

Who actually sold the HNGE shares in this Form 4 filing?

The sales were made by Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P., referred to as the Bessemer Funds. The filing reports these sales because reporting person Robinson Elliott is a partner associated with these funds.

Does Robinson Elliott claim beneficial ownership of the HNGE shares sold?

No. Robinson Elliott has an indirect, passive economic interest through interests in Deer X & Co. L.P. and certain Bessemer Funds and disclaims beneficial ownership of the securities, except to the extent of any pecuniary interest in those funds.

Were the reported HNGE share sales executed at a single price?

No. The sales are reported using weighted average prices. August 25 sales averaged $91.08 with prices from $90.50 to $91.20, and August 26 sales averaged $91.71 with prices from $91.20 to $92.07.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/27/2026 - 05:16 PM Accepted by SEC EDGAR 08/27/2026 - 05:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Robinson Elliott

(Last) (First) (Middle)

C/O BESSEMER VENTURE PARTNERS

1865 PALMER AVENUE, SUITE 104

(Street)

LARCHMONT NEW YORK 10538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/25/2026		S		0(1)	D	$0	0	I	See footnote(1)(2)
Class A Common Stock	08/26/2026		S		0(1)	D	$0	0	I	See footnote(2)(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On August 25, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 115,202 and 108,144 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.08. These shares were sold in multiple transactions at prices ranging from $90.50 to $91.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.

3. On August 26, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 58,484 and 55,243 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.71. These shares were sold in multiple transactions at prices ranging from $91.20 to $92.07. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

	/s/ Augie Wilkinson, Attorney-in-Fact	08/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)